These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23903338)

  • 1. Bipolar disorder, schizophrenia, and metabolic syndrome.
    Bartoli F; Carrà G; Crocamo C; Carretta D; Clerici M
    Am J Psychiatry; 2013 Aug; 170(8):927-8. PubMed ID: 23903338
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Bartoli et al.
    Vancampfort D; Mitchell AJ; Correll CU; Sienaert P; De Hert M
    Am J Psychiatry; 2013 Aug; 170(8):928-9. PubMed ID: 23903339
    [No Abstract]   [Full Text] [Related]  

  • 3. Medical monitoring in patients with bipolar disorder: a review of data.
    Fagiolini A
    J Clin Psychiatry; 2008 Jun; 69(6):e16. PubMed ID: 18683991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Awareness of metabolic concerns in patients with bipolar disorder: a survey of European psychiatrists.
    Bauer M; Lecrubier Y; Suppes T
    Eur Psychiatry; 2008 Apr; 23(3):169-77. PubMed ID: 18160267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvements in metabolic abnormalities among overweight schizophrenia and bipolar disorder patients.
    Ventriglio A; Gentile A; Baldessarini RJ; Martone S; Vitrani G; La Marca A; Bellomo A
    Eur Psychiatry; 2014 Sep; 29(7):402-7. PubMed ID: 24439513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin-Induced Type 1 Hypersensitivity in a Child with Antipsychotic-Induced Weight Gain.
    Mennella C; Dickstein DP
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):106-107. PubMed ID: 27548055
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic syndrome and bipolar disorder: what should psychiatrists know?
    de Almeida KM; Moreira CL; Lafer B
    CNS Neurosci Ther; 2012 Feb; 18(2):160-6. PubMed ID: 22070636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical risk in patients with bipolar disorder and schizophrenia.
    Newcomer JW
    J Clin Psychiatry; 2006 Nov; 67(11):e16. PubMed ID: 17201046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review and Meta-Analysis of Metabolic Syndrome Prevalence in Chinese Inpatients with Bipolar Disorder.
    Tao H; Shen D; Zhou Y; Sun F; Li G; Jin W
    Horm Metab Res; 2022 Sep; 54(9):587-592. PubMed ID: 35738391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome in patients with schizophrenia: CATIE results.
    Narasimhan M; Masand P
    Curr Psychiatry Rep; 2006 Jun; 8(3):213-4. PubMed ID: 19817071
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucose testing in patients receiving antipsychotic pharmacotherapy.
    Strouss L; Schuster J; Dogin J; Sorbero M; Mihalyo M
    Psychopharmacol Bull; 2008; 41(2):5-6; author reply 7-8. PubMed ID: 18668011
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE).
    Sylvia LG; Shelton RC; Kemp DE; Bernstein EE; Friedman ES; Brody BD; McElroy SL; Singh V; Tohen M; Bowden CL; Ketter TA; Deckersbach T; Thase ME; Reilly-Harrington NA; Nierenberg AA; Rabideau DJ; Kinrys G; Kocsis JH; Bobo WV; Kamali M; McInnis MG; Calabrese JR
    Bipolar Disord; 2015 Mar; 17(2):212-23. PubMed ID: 25130321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome in mental illness: evidence and way out.
    Saddichha S
    Int J Clin Pharmacol Ther; 2010 Jan; 48(1):84-6. PubMed ID: 20040344
    [No Abstract]   [Full Text] [Related]  

  • 14. Medical risk in patients with bipolar disorder and schizophrenia.
    Newcomer JW
    J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and schizophrenia.
    Reynolds GP
    Br J Psychiatry; 2006 Jan; 188():86; author reply 86-7. PubMed ID: 16411336
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications.
    Penninx BWJH; Lange SMM
    Dialogues Clin Neurosci; 2018 Mar; 20(1):63-73. PubMed ID: 29946213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between bipolar disorder and metabolic syndrome: A review.
    Taylor V; MacQueen G
    J Clin Psychiatry; 2006 Jul; 67(7):1034-41. PubMed ID: 16889445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder.
    Salvi V; Barone-Adesi F; D'Ambrosio V; Albert U; Maina G
    Psychopharmacology (Berl); 2016 Jan; 233(1):49-56. PubMed ID: 26407602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome with different antipsychotics: a multicentre cross-sectional study.
    Cerit C; Vural M; Bos Gelmez SÜ; Ozten E; Aker AT; Yıldız M
    Psychopharmacol Bull; 2010; 43(4):22-36. PubMed ID: 21240150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators.
    Vancampfort D; Vansteelandt K; Correll CU; Mitchell AJ; De Herdt A; Sienaert P; Probst M; De Hert M
    Am J Psychiatry; 2013 Mar; 170(3):265-74. PubMed ID: 23361837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.